Z-0590-2021 Class II Terminated

Recalled by Enterix, Inc. — Edison, NJ

FDA device recall Z-0590-2021 was initiated by Enterix, Inc. on Oct 8, 2020 and is designated Class II. Reason for recall: Product does not meet internal testing criterion; use of the product may result in a potential false positive test result and may lead to patients undergoing unnecessary follow-up diagnostic… The recall status is terminated (terminated Jan 10, 2023). Affected quantity: US: 5,256 vials (131,400 test strips); OUS:1051 vials.

Recall details

Product Type
Devices
Report Date
Dec 23, 2020
Initiation Date
Oct 8, 2020
Termination Date
Jan 10, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
US: 5,256 vials (131,400 test strips); OUS:1051 vials

Product description

InSure ONE Test Strips (25 pack) vials-fecal immunochemical test (FIT) qualitatively detects human hemoglobin from blood in fecal samples Model 12045.01.

Reason for recall

Product does not meet internal testing criterion; use of the product may result in a potential false positive test result and may lead to patients undergoing unnecessary follow-up diagnostic procedure, i.e., colonoscopy or sigmoidoscopy

Distribution pattern

Worldwide distribution - US Nationwide and the country of Australia.

Code information

Lot Numbers: 770G11 and 770G21

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0590-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0590-2021. Report a data issue: hello@regdatalab.com.